Internet CME Course: Shared Decision Making: Essential Skills for Prostate, Lung & Breast Cancer Screening – Module 3 – Shared Decision Making for Screening in Patients at Higher Risk for Cancer

Activity ID

2812

Expires

September 12, 2024

Format Type

Internet

CME Credit

1

Fee

$0

CME Provider: Massachusetts Medical Society

Description of CME Course

Part 1: Recommendations and Information for Patients at Increased Risk for Cancer: Basic Principles
Module 3 features presentations about screening patients at higher than average risk for cancer. Roger Luckmann, MD, MPH explains how recommendations for screening high risk patients are usually developed and reviews the assumptions that may be made in calculating likelihoods of benefits and harms in high risk patients. He reviews the rationale and related assumptions for starting screening at an earlier age for some high-risk patients, for shortening the interval between screens, and for lowering the threshold for a positive test. He suggests some approaches to discussing cancer screening with patients at significantly higher risk than average.

Part 2: Shared Decision Making for Men at Increased Risk for Cancer
The second presentation on SDM for prostate cancer screening for high-risk men is by Mark Kennedy, MBA. This presentation focuses on screening for African American men but addresses SDM for all high-risk men. Mark reviews the established risk factors for prostate cancer of age, race and family history and the potential harms and benefits of PSA testing and of other tests and treatments on the prostate cancer care continuum for men at high risk that differ from men at average risk. He addresses the potential effect of variations in care and the possible implications of not screening high-risk men. The presentation includes a review of existing screening guidelines and what they mean for high-risk men, and the goals of screening for these men. For men and their doctors, the presentation provides an approach and rationale for screening high-risk men in the absence of Level 1 research evidence for this group.

Participants will view a brief video simulating an SDM discussion for prostate cancer with an African American patient and hear commentary from Mark on the video that frames how SDM can be conducted most appropriately for this population. Mark concludes with a review of key considerations for utilizing SDM as a first step in mitigating the harms of PSA testing for high-risk men.

Register for this Activity